-transparent.png){kind=logo}
The bladder capacities of 75 patients with superficial bladder tumors were measured prior to and during monthly intravesical instillation therapy with adriamycin. When taken off therapy, a decrease in bladder capacity of more than 20% was observed in 18 of the patients. In 14 of the treated patients an increase in bladder capacity of more than 20% was observed. In patients with reduced bladder capacity when taken off therapy, there were no correlations between the degree of decreased bladder capacity and the number of instillations or the total instilled amount of adriamycin, indicating that the observed decrease in bladder capacity was caused by the underlying disease and not by the treatment per se.
S Eksborg, and
F Edsmyr, and
I Andersson
January 1992,
Cancer chemotherapy and pharmacology,
S Eksborg, and
F Edsmyr, and
I Andersson
January 1984,
Progress in clinical and biological research,
S Eksborg, and
F Edsmyr, and
I Andersson
June 1983,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
S Eksborg, and
F Edsmyr, and
I Andersson
March 1984,
Urology,
S Eksborg, and
F Edsmyr, and
I Andersson
April 1999,
Gan to kagaku ryoho. Cancer & chemotherapy,
S Eksborg, and
F Edsmyr, and
I Andersson
November 1985,
Hinyokika kiyo. Acta urologica Japonica,
S Eksborg, and
F Edsmyr, and
I Andersson
June 1980,
Urology,
S Eksborg, and
F Edsmyr, and
I Andersson
January 1985,
Der Urologe. Ausg. A,
S Eksborg, and
F Edsmyr, and
I Andersson
January 1983,
Cancer chemotherapy and pharmacology,
S Eksborg, and
F Edsmyr, and
I Andersson
January 1983,
Cancer chemotherapy and pharmacology,
